Ejemplo: Heart Attack

Ensayos clínicos sobre Tumor neuroendocrino pancreático

Total 181 resultados

NCT04134832

Reclutamiento

Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region

Condiciones: Pancreatic Neuroendocrine Tumor
NCT03204019

Estado desconocido

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Condiciones: Pancreatic Neuroendocrine Tumor
NCT03741517

Reclutamiento

Biomarker Study of Pancreatic Neuroendocrine Tumours

Condiciones: Pancreatic Neuroendocrine Tumor
NCT02624154

Estado desconocido

Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Condiciones: Pancreatic Neuroendocrine Tumor
NCT03947762

Reclutamiento

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Condiciones: Pancreatic Neuroendocrine Tumor
NCT02841865

Completado

Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria

Condiciones: Pancreatic Neuroendocrine Tumors
NCT01658436

Completado

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

Condiciones: Pancreatic Neuroendocrine Tumors (pNET)
NCT04544098

Reclutamiento

Lutathera in People With Pancreatic Neuroendocrine Tumors That Have Spread to the Liver

Condiciones: Pancreatic Neuroendocrine Tumors; Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
NCT02282059

Reclutamiento

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

Condiciones: Pancreatic Neuroendocrine Tumors
NCT02713763

Completado

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib

Condiciones: Pancreatic Neuroendocrine Tumour Metastatic
NCT01121562

Completado

Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Condiciones: Pancreatic Neuroendocrine Tumors
NCT02736448

Activo, no reclutando

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors

Condiciones: Gastro-entero-pancreatic Neuroendocrine Tumors
NCT02705651

Aún no reclutando

Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment

Condiciones: Pancreatic Neuroendocrine Tumors in MEN1
NCT00576680

Completado

RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors

Condiciones: Pancreatic Neuroendocrine Tumor
NCT01845675

Completado

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

Condiciones: Advanced Well-differentiated Pancreatic Neuroendocrine Tumor
NCT02288377

Completado

A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)

Condiciones: Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
NCT01628913

Terminado

Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

Condiciones: Pancreatic Neuroendocrine Tumors (pNET)
NCT03967951

Completado

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Condiciones: Pancreatic Neuroendocrine Tumor
NCT01525550

Completado

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Condiciones: Well-differentiated Pancreatic Neuroendocrine Tumor
NCT02305810

Completado

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Condiciones: Pancreatic Neuroendocrine Tumour Metastatic
NCT02736500

Activo, no reclutando

Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors

Condiciones: Neuroendocrine Tumors; Gastro Entero Pancreatic Neuroendocrine Tumors
NCT02893930

Activo, no reclutando

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Condiciones: Pancreatic Neuroendocrine Tumor G1; Pancreatic Neuroendocrine Tumor G2; Refractory Pancreatic Neuroendocrine Carcinoma
NCT02759718

Estado desconocido

Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors

Condiciones: Non Functioning Pancreatic Endocrine Tumor
NCT02125929

Completado

Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms

Condiciones: Pancreatic Neuroendocrine Tumors
NCT02842749

Activo, no reclutando

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

Condiciones: Pancreatic Neuroendocrine Tumors